Gene Editing of HBG1 and HBG2 Promotors to Treat β-Thalassemia and Sickle Cell Disease β-thalassemia and sickle cell disease (SCD) are the most common monogenic diseases worldwide. About 20% of these patients may be… April 28, 2026
Jehovah’s Witness Governing Body Allows Autologous Transfusions Jehovah’s Witnesses (JWs) are a Christian denomination founded in the late 19th century in the United States with a focus… April 23, 2026
RBC Exchange Transfusion for Patients with Severe Babesiosis Babesiosis is a tick-borne disease primarily transmitted by the intraerythrocytic protozoa Babesia microti in the U.S., which causes malaria-like symptoms… April 14, 2026
Oropouche Virus RNA Detected in Blood Donors in Brazil The oropouche virus (OROV) is primarily transmitted by Culicoides paraensis midges but transmission also occurs by some Culex mosquitoes and… April 8, 2026
Intravenous Iron More Effective than Oral to Treat Anemia in Postpartum Women Although the prevalence of postpartum anemia is common—as high as 50% in high-income countries and 80% in low- and… April 1, 2026
Prehospital Whole Blood is Not Superior to Blood Components for Trauma Patients Observational studies suggest that prehospital whole blood may offer benefits over blood components in trauma patients, including a reduction in… March 26, 2026
Pathogen Reduction of Platelets and Risk of Transfusion-Transmitted Bacterial Infections Pathogen reduction (PR) systems decrease the risk of transfusion-transmitted infections (TTI), and many blood centers use PR to treat platelets… March 18, 2026
Techniques to Reduce Anxiety, Distress, and Pain for First Time Apheresis Donors Distraction techniques such as listening to music, squeezing a stress ball, and watching movies have been shown to reduce anxiety,… March 11, 2026
Running Ultra-Long Distances Induces Inflammatory and Oxidative Stress Changes in RBCs While moderate exercise improves cardiovascular health, marathons and ultra-long-distance running may damage RBCs, cause premature “aging,” and lower hematocrits. A… March 4, 2026
Tranexamic Acid for Patients with Hematological Disorders Patients with hematological disorders are often thrombocytopenic due to the pathology of their disease and/or treatment. Platelet transfusions, used both… February 26, 2026
